Holen Sie sich die Stockscreener-App
6.95
3.89%
0.26
Handel nachbörslich:
6.94
-0.010
-0.14%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$6.69
Offen:
$6.77
24-Stunden-Volumen:
2.71M
Relative Volume:
0.58
Marktkapitalisierung:
$1.13B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$422.82M
KGV:
3.0482
EPS:
2.28
Netto-Cashflow:
$-637.33M
1W Leistung:
+9.62%
1M Leistung:
-18.43%
6M Leistung:
-4.14%
1J Leistung:
-20.57%
1-Tages-Spanne:
$6.72
$6.98
1-Wochen-Bereich:
$6.20
$6.98
52-Wochen-Spanne:
$5.01
$11.55
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Vergleichen Sie NVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
6.95 | 1.09B | 1.08B | 422.82M | -637.33M | 2.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Shah Capital continues push for potential Novavax sale - Alternatives Watch
Milestones Over Sales: The Sanofi Partnership Now Drives Novavax’s Outlook (NVAX) - Seeking Alpha
January 2026 Options Now Available For Novavax (NVAX) - Nasdaq
Novavax’s R&D Shift and Sanofi Partnership Could Be a Game Changer for NVAX - Yahoo Finance
What Recent Partnership Efforts Mean for the Value of Novavax in 2025 - Yahoo Finance
Novavax slips as Citi launches with Sell rating on pipeline concerns - MSN
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - Yahoo Finance
Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast - Finviz
Novavax Inc. stock rises Monday, still underperforms market - MarketWatch
9 Oversold Biotech Stocks to Invest In - Insider Monkey
Novavax rises after a seven-day slide - MSN
Behavioral Patterns of NVAX and Institutional Flows - news.stocktradersdaily.com
Novavax, UniFirst, and More Stocks See Action From Activist Investors - Barron's
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Interesting NVAX Put And Call Options For July 2026 - Nasdaq
How rising interest rates impact Novavax Inc. stockWeekly Risk Report & Reliable Intraday Trade Alerts - newser.com
Is Novavax Inc. stock undervalued vs historical averagesJuly 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Will Novavax Inc. (NVV1) stock hit Wall Street targets2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Why Novavax Inc. stock appeals to dividend seekers2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
How Novavax Inc. (NVV1) stock gains from tech spendingOptions Play & Risk Controlled Stock Pick Alerts - newser.com
Is Novavax Inc. stock a buy on dipsJuly 2025 Short Interest & Long-Term Growth Plans - newser.com
earlytimes> 2025> Is Novavax Inc a good long term investmentCash Flow Trends & Small Investment Wealth Growth - earlytimes.in
Published on: 2025-11-20 05:45:01 - newser.com
Will Novavax Inc. stock maintain growth storyJuly 2025 Highlights & Real-Time Volume Analysis - newser.com
Will Novavax Inc. (NVV1) stock split increase liquidityEarnings Risk Report & Technical Confirmation Alerts - newser.com
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Published on: 2025-11-19 15:40:01 - newser.com
Notable Wednesday Option Activity: NVAX, BLK, MP - Nasdaq
Why pension funds invest in Novavax Inc. (NVV1) stockTrade Volume Report & Scalable Portfolio Growth Methods - newser.com
NVAX: Strategic partnerships and Matrix-M platform drive growth, targeting major vaccine markets - TradingView
Novavax at Jefferies London: Strategic Shift to Partnerships By Investing.com - Investing.com Canada
Is Novavax Inc. stock in correction or buying zoneJuly 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Can Novavax Inc. stock rebound after recent weaknessJuly 2025 Technicals & Low Risk Entry Point Guides - newser.com
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
2.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):